Valuation: PolarCool AB

Market Cap 17.66M 1.77M 1.58M 1.47M 1.34M 2.51M 171M 2.54M 6.91M 86.91M 6.63M 6.49M 280M P/E 2024
-1.25x
P/E 2025 -1.46x
Enterprise Value 16.26M 1.63M 1.45M 1.35M 1.23M 2.31M 157M 2.34M 6.36M 80M 6.1M 5.97M 257M EV / Sales 2024
12.7x
EV / Sales 2025 9.92x
Free-Float
99%
Yield 2024 *
-
Yield 2025 -
1 day-2.56%
1 month+0.66%
3 months-20.00%
6 months-48.30%
Current year-66.22%
1 month 0.96
Extreme 0.955
2
Current year 0.96
Extreme 0.955
4.94
1 year 0.96
Extreme 0.955
4.94
3 years 0.96
Extreme 0.955
150
5 years 0.96
Extreme 0.955
1,854
10 years 0.96
Extreme 0.955
9,600
Manager TitleAgeSince
Chief Executive Officer 44 -
Chief Tech/Sci/R&D Officer - 2024-04-30
Comptroller/Controller/Auditor 30 -
Director TitleAgeSince
Chairman 79 2017-12-31
Chairman - 2022-01-05
Chairman 45 -
Change 5-day change 1-year change 3-year change Capi.($)
-2.56%-.--%-63.11%-97.19% 1.76M
-3.19%-3.19%+44.60%+87.98% 74.68B
-15.86%-16.16%+2.68%+51.09% 58.7B
-2.39%+0.50%+3.41%+31.33% 48.36B
-6.35%-8.63%+293.39%+638.59% 43.05B
+0.30%-0.71%+29.05%+29.74% 42.48B
-3.82%-2.41%-0.27%+102.63% 41.39B
-2.13%+1.07%+7.51%+50.31% 31.29B
-3.35%-4.95%-13.38%-15.78% 23.93B
-1.24%-7.47%-37.90%+309.96% 22.22B
Average -4.04%-4.19%+26.60%+118.87% 38.61B
Weighted average by Cap. -4.84%-1.88%+42.94%+135.13%

Financials

2024 2025
Net sales 2.08M 208K 186K 174K 158K 297K 20.17M 299K 815K 10.25M 782K 765K 32.96M 2.4M 240K 214K 200K 181K 341K 23.21M 345K 937K 11.79M 900K 880K 37.93M
Net income -11.02M -1.1M -984K -918K -834K -1.57M -107M -1.58M -4.31M -54.25M -4.14M -4.05M -174M -16.73M -1.67M -1.49M -1.39M -1.27M -2.38M -162M -2.4M -6.54M -82.31M -6.28M -6.14M -265M
Net Debt -7.38M -738K -659K -615K -558K -1.05M -71.46M -1.06M -2.89M -36.31M -2.77M -2.71M -117M -1.4M -140K -125K -117K -106K -200K -13.6M -202K -549K -6.91M -527K -516K -22.23M
Projected Income Statement - Annual - PolarCool AB
Logo PolarCool AB
Polarcool AB is a Sweden-based medical device company that offers a controlled cooling treatment. The Company provides solutions on concussive and sub-concussive brain injuries such as PolarCap System. The device PolarCap System is intended as an acute treatment for concussion, as soon as possible after injury. PolarCap aims to reduce the metabolic demand in the brain, when a concussion occurs during sports. By lowering brain temperature rapidly through controlled cooling. With this System, the Company protects the athletes, their clubs as well as the financial losses occurring while an athlete recovers or having to quit the sport altogether. PolarCool AB is based in Lund, Sweden and the shares are listed on Spotlight Stock Market.
Employees
4
Date Price Change Volume
26-09-30 SEK 1.520 -2.56% 1
26-09-29 SEK 1.560 -10.34% 16,727
  1. Stock Market
  2. Stocks
  3. POLAR Stock